Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,530 | -6,227 | -6,171 | -3,182 | -2,140 |
| Depreciation Amortization | -149 | -103 | -39 | -26 | -13 |
| Other Working Capital | 125 | -189 | -213 | -304 | -124 |
| Other Operating Activity | 3 | -101 | 877 | -384 | 360 |
| Operating Cash Flow | $-1,552 | $-6,620 | $-5,546 | $-3,896 | $-1,917 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,850 | 1,850 | 1,850 | N/A |
| PPE Investments | -1 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 135 | 340 | 1,215 | 668 | 156 |
| Investing Cash Flow | $134 | $2,190 | $3,065 | $2,518 | $156 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 926 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 7,129 | N/A | N/A | N/A |
| Financing Cash Flow | $N/A | $8,055 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 13,487 | 9,862 | 9,862 | 9,862 | 9,862 |
| End Cash Position | 12,069 | 13,487 | 7,380 | 8,483 | 8,101 |
| Net Cash Flow | $-1,418 | $3,625 | $-2,482 | $-1,379 | $-1,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,552 | -6,620 | -5,546 | -3,896 | -1,917 |
| Capital Expenditure | -1 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,552 | -6,620 | -5,546 | -3,896 | -1,917 |